<?xml version="1.0" encoding="UTF-8"?>
<ref id="B10-materials-13-04532">
 <label>10.</label>
 <element-citation publication-type="book">
  <person-group person-group-type="author">
   <name>
    <surname>Halamoda-Kenzaoui</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Box</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>van Elk</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Gaitan</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Geertsma</surname>
    <given-names>R.E.</given-names>
   </name>
   <name>
    <surname>Gainza Lafuente</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Owen</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Del Pozo</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Roesslein</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Bremer-Hoffmann</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <source>Anticipation of Regulatory Needs for Nanotechnologyâ€”Enabled Health Products</source>
  <comment>The REFINE White Paper</comment>
  <publisher-name>Publications Office of the European Union</publisher-name>
  <publisher-loc>Luxembourg</publisher-loc>
  <year>2019</year>
  <pub-id pub-id-type="doi">10.2760/596822</pub-id>
 </element-citation>
</ref>
